These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection. Von Landenberg P, Lehmann HW, Knöll A, Dorsch S, Modrow S. Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688 [Abstract] [Full Text] [Related]
12. Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin. Ohtsuka T, Yamazaki S. Br J Dermatol; 2004 Jun 01; 150(6):1091-5. PubMed ID: 15214893 [Abstract] [Full Text] [Related]
15. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood. Lehmann HW, Knöll A, Küster RM, Modrow S. Arthritis Rheum; 2003 Jun 01; 48(6):1631-8. PubMed ID: 12794831 [Abstract] [Full Text] [Related]
16. [Neutropenia and/or thrombocytopenia due to acute parvovirus B19 infection]. Frotscher B, Salignac S, Morlon L, Bonmati C, Jeulin H, Venard V, Lecompte T. Ann Biol Clin (Paris); 2009 Jun 01; 67(3):343-8. PubMed ID: 19411238 [Abstract] [Full Text] [Related]